Vanguard Group Inc. Sells 46,676 Shares of CorVel Corp. $CRVL

Vanguard Group Inc. lowered its holdings in CorVel Corp. (NASDAQ:CRVL) by 1.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,241,112 shares of the business services provider’s stock after selling 46,676 shares during the period. Vanguard Group Inc. owned approximately 0.06% of CorVel worth $219,326,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. State Street Corp boosted its holdings in CorVel by 1.9% in the 2nd quarter. State Street Corp now owns 1,093,710 shares of the business services provider’s stock valued at $112,412,000 after purchasing an additional 20,537 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of CorVel by 14.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 458,326 shares of the business services provider’s stock valued at $35,484,000 after acquiring an additional 58,323 shares during the period. Qube Research & Technologies Ltd lifted its position in shares of CorVel by 100.9% during the 3rd quarter. Qube Research & Technologies Ltd now owns 236,713 shares of the business services provider’s stock valued at $18,326,000 after acquiring an additional 118,879 shares during the period. Raymond James Financial Inc. lifted its position in shares of CorVel by 1.3% during the 3rd quarter. Raymond James Financial Inc. now owns 221,070 shares of the business services provider’s stock valued at $17,115,000 after acquiring an additional 2,798 shares during the period. Finally, Algert Global LLC lifted its position in shares of CorVel by 73.4% during the 3rd quarter. Algert Global LLC now owns 217,559 shares of the business services provider’s stock valued at $16,843,000 after acquiring an additional 92,077 shares during the period. Institutional investors own 51.36% of the company’s stock.

CorVel Trading Up 0.8%

Shares of NASDAQ:CRVL opened at $58.52 on Friday. The firm has a 50 day moving average of $54.45 and a 200-day moving average of $62.84. The stock has a market capitalization of $2.99 billion, a PE ratio of 28.69 and a beta of 0.98. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $117.22.

Insider Activity at CorVel

In other news, insider Maxim Shishin sold 2,400 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $54.00, for a total value of $129,600.00. Following the completion of the transaction, the insider directly owned 7,050 shares in the company, valued at approximately $380,700. The trade was a 25.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 44.56% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, April 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, CorVel presently has an average rating of “Sell”.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).